Because EGFR signaling activates ARF6 and induces breast cancer invasion, we tested whether impaired EGFR signaling could reproduce the intrahepatic biliary defects observed in arf6-ATG MO-injected larvae [50]. Here, ARF6 is linked to breast carcinoma.